Viewing Study NCT00685256



Ignite Creation Date: 2024-05-05 @ 7:30 PM
Last Modification Date: 2024-10-26 @ 9:50 AM
Study NCT ID: NCT00685256
Status: COMPLETED
Last Update Posted: 2017-05-17
First Post: 2008-05-24

Brief Title: Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA12 Testing and Their Minor-Age Children
Sponsor: Georgetown University
Organization: Georgetown University

Study Overview

Official Title: Parent Communication Study II - Randomized Controlled Trial of Decision Support vs Education for Parent Communication of BRCA 12 Cancer Genetic Test Results to Children
Status: COMPLETED
Status Verified Date: 2017-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE A study that evaluates the support of a decision guide used together with genetic counseling may improve communication between mothers undergoing BRCA12 testing and their minor-age children

PURPOSE This randomized phase III trial is studying standard genetic counseling given together with a decision guide to see how well it works compared with genetic counseling alone in improving communication between mothers undergoing BRCA12 testing and their minor-age children
Detailed Description: OBJECTIVES

Primary

To evaluate the efficacy of a decision support intervention delivered in conjunction with standard genetic counseling compared to standard genetic counseling alone in improving communication between mothers undergoing BRCA12 testing and their minor-age children

Secondary

To understand the mechanisms by which decision support impacts on decision outcomes
To identify mothers who are most and least likely to benefit from decision support
To explore the potential impact of decision support on disclosure and parent-child psychosocial well-being

OUTLINE This is a multicenter study Mothers are stratified according to their childs age 13 vs 13 years old childs gender female vs male and trial site Mothers are randomized to 1 of 2 arms

Arm I standard genetic counseling with communication aid Mothers undergo standard pre-test genetic counseling and provide a blood sample for mutation analysis Mothers also receive a copy of My Children My Test Results a detailed decision guide developed to promote quality and informed decision making and outcomes and provide support to mothers regardless of whether or not they choose to communicate their BRCA12 test results to their children
Arm II standard genetic counseling alone Mothers undergo standard pre-test genetic counseling and provide a blood sample for mutation analysis Mothers also receive a copy of Genetic Testing for Breast and Ovarian Cancer Risk Its Your Choice containing information regarding family history of breast and ovarian cancer risks BRCA12 genes risks and benefits of genetic testing medical management options for carriers and considerations including family communication

All mothers complete extensive family history assessments during their baseline interviews and disclose if they have been diagnosed with cancer length and type of treatments and the number of other relatives with a history of cancer Mothers are assessed at baseline pre-test genetic counseling post-genetic counseling after learning test results and at 1 and 6 months post-genetic counseling by a 30-45 minute multi-item and multi-scale self-report telephone survey Genetic testing results are also submitted to this study The frequency number intensity length in minutes and content of participant-initiated telephone contacts to genetic counselors to assess intervention reactivity participants self-reported use of educational guides and their satisfaction with the intervention will be assessed

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
GUMC-2007-444 US NIH GrantContract None httpsreporternihgovquickSearchP30CA051008
R01HG002686 NIH None None
P30CA051008 NIH None None